Echosens
Created in 2001
Up & running (A)
Existing signals show a regular activitySocial networks
1,229 20,716Activities
Entity types
Location
6 Rue Ferrus, 75014 Paris, France
Paris
France
Employees
Scale: 201-500
Estimated: 323
SIREN
438209157Engaged catalyst
10
0 0Added in Motherbase
5 years, 5 months ago
Value proposition
We are shaping the future of liver health. Because Liver Health Matters.
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.
As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
Diagnostic non-invasif en hépatologie, Pionnier en Elastographie quantitative, and Evaluation de la fibrose hépatique et de la cirrhoseOriginal language
Nous façonnons le futur de la santé du foie. Because liver health matters
Pionnier dans son domaine, Echosens a modifié considérablement la pratique du diagnostic des maladies du foie avec FibroScan®, la solution non invasive de référence pour une prise en charge globale de la santé du foie.
FibroScan® est reconnu dans le monde entier comme l’outil de référence pour l'évaluation de la fibrose et de la stéatose hépatiques avec plus de 4 200 publications soumises à des comités de lecture et plus de 180 recommandations internationales.
Echosens distribue FibroScan® dans plus de 100 pays, permettant ainsi la réalisation de millions d'examens du foie dans le monde entier.
FibroScan®, the non-invasive solution for liver disease - ECHOSENS
Echosens manufactures FibroScan®, a non-invasive solution that accurately measures liver stiffness and liver steatosis for a comprehensive management of liver disease.
https://www.echosens.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 5 Apr 2025 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 25 Sep 2023 | | |
 Welcome to the Jungle France Human ressources, Software Development | Welcome to the Jungle France Human ressources, Software Development | Other 4 Apr 2025 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Dec 2016 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 6 Mar 2020 | | |
 UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Not capitalistic Partnership Not event 23 Jan 2020 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 24 Jun 2016 | | |
 Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Jun 2024 | | |
 ESPCI Paris - PSL Startup accelerator & VC, Higher Education | ESPCI Paris - PSL Startup accelerator & VC, Higher Education | Other 10 Dec 2019 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Not capitalistic Not partnership Event 7 Jun 2016 | | |